Dr. Javier Alonso-Llamazares, MD, PhD

Dr. Alonso-Llamazares practices at Javier Alonso MD PA in Miami, Florida.

Dr. Alonso-Llamazares' NPI, 1356315485, was assigned on February 15, 2006. Dr. Alonso-Llamazares graduated from Universidad de Navarra Faculty of Medicine in 1989. Dr. Alonso-Llamazares holds Florida license ME97488.

Dr. Alonso-Llamazares' primary practice is Javier Alonso MD PA, at 8370 W Flagler St, Miami, FL 33144 in Miami-Dade County. The practice phone is (305) 443-2983.

Dr. Alonso-Llamazares' primary practice is Javier Alonso MD PA in Miami, Florida. Dmand AI also links Dr. Alonso-Llamazares to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alonso-Llamazares practices. Vendor and product names are available with a free account.

Dermatology is Dr. Alonso-Llamazares' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Alonso-Llamazares is board certified in dermatology by the American Board of Dermatology. Dr. Alonso-Llamazares is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Alonso-Llamazares treats.

CMS data shows 5,397 Medicare services from Dr. Alonso-Llamazares across 21 procedure codes in 2024, for 283 Medicare patients. Medicare paid $153,397 for them. Every service was in an office.

CMS counts 283 Medicare patients who saw Dr. Alonso-Llamazares in 2024. The largest group is 75 to 84, with 124 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alonso-Llamazares' median patient age at 61, with 50% women.

In 2024, Dr. Alonso-Llamazares wrote 653 Medicare Part D claims for 187 patients. 85% of them were for generic drugs. CMS names the drug for 490 of them, across 19 drugs with 11 or more claims each, at $336,887 in total drug cost. In 2023, CMS named 446 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Alonso-Llamazares for performance year 2024, reported individually. Dr. Alonso-Llamazares accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 643 procedures of removal of skin lesions by Dr. Alonso-Llamazares, more than 89% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Alonso-Llamazares, published from 2008 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Double-Blind Method, Immunoglobulin A and Psoriasis. Dr. Alonso-Llamazares has published most often in Int J Dermatol. Dr. Alonso-Llamazares' most frequent co-authors are Leon H. Kircik, MD, Patrick Burnett, MD and Zoe Diana Draelos, MD.

Dmand AI links Dr. Alonso-Llamazares to 8 clinical trials, 3 of them phase 3 studies. Conditions studied include Acneiform Eruptions, Hyperhidrosis and Acne Vulgaris. Journey Medical Corporation sponsors the most, 2. Open Payments lists research payments to Dr. Alonso-Llamazares that name 4 trials.

CMS Open Payments shows 2,168 general payments to Dr. Alonso-Llamazares from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Arcutis Biotherapeutics, Inc. paid the most, $228,932. It also lists 20 research payments totaling $285,873 from 2016 to 2024, naming 4 clinical trials.

Dmand AI lists 1 award for Dr. Alonso-Llamazares.

Dr. Alonso-Llamazares graduated from Universidad de Navarra Faculty of Medicine in 1989. Dr. Alonso-Llamazares is a member of AAD.

Dr. Alonso-Llamazares is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.